silybin has been researched along with pyrazolanthrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fan, S; Ikejima, T; Li, L; Onodera, S; Qi, M; Tashiro, S; Yao, G; Yu, Y | 1 |
2 other study(ies) available for silybin and pyrazolanthrone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
Topics: Anthracenes; Apoptosis; Apoptosis Regulatory Proteins; Benzothiazoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Genes, p53; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Reactive Oxygen Species; Silybin; Silymarin; Toluene; Tumor Suppressor Protein p53; Vulvar Neoplasms | 2012 |